An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.

Guests

  • Dr. Peter Bach attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
  • Dr. Carolyn Hendricks a medical oncologist affiliated with Suburban Hospital in Bethesda.
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Gardiner Harris science reporter for "The New York Times" and author of the mystery novel 'Hazard.'

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Verdine White On 45 Years With Earth, Wind & Fire

Monday, Jul 25 2016Forty-five years ago, the band “Earth, Wind and Fire” introduced audiences to a new kind of funk--one that fused soul, jazz, Latin and pop. Bassist Verdine White talks to guest host Derek McGinty about breaking racial boundaries in music and how the band is still evolving.

Friday News Roundup – International

Friday, Jul 22 2016Turkey declares a state of emergency and arrests thousands after a failed coup. Donald Trump suggests he'd put conditions on protecting NATO allies. And Russia loses an appeal in a sports doping case. A panel of journalists joins guest host Frank Sesno for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Jul 22 2016The Republican National Convention ends with a divided GOP. Hillary Clinton prepares to select her running mate. And Roger Ailes resigns from Fox News over sexual harassment allegations. A panel of journalists joins guest host Frank Sesno for analysis of the week's top international news stories.